Literature DB >> 10382850

Effect of reaction conditions on preparations of rhenium-188 hydroxyethylidene diphosphonate complexes.

W Y Lin1, J F Hsieh, C P Lin, B T Hsieh, G Ting, S J Wang, F F Knapp.   

Abstract

Rhenium-186 (Re-186) hydroxyethylidene diphosphonate (HEDP) has been shown to localize in metastatic foci within bone in a manner similar to Tc-99m bone-seeking agents. Usually, in the preparation of diagnostic Tc-99m radiopharmaceuticals, the concentration of Tc is at trace level (10(-8) M). However, large amounts of carrier are included in the preparation of Re-186 radiopharmaceuticals (10(-4) M), which may significantly affect the preparation of Re-HEDP. In this study, Re-188 was used as an Re tracer. The effects of pH and concentrations of Re carrier on the preparation of Re-HEDP were investigated. Re-188-Sn-HEDP was prepared by reconstitution of a kit of lyophilized HEDP mixture, and tin chloride with a radioactive solution of perrhenate in saline. The total concentration of Re present in this work ranged from 10(-8) to 10(-3) M. The results showed that high labeling efficiency was obtained for each preparation. Although the chemical behaviors of the Re-188 HEDP complexes, with and without carrier, were similar, the biodistribution patterns of carrier free Re-188 HEDP in rats were found to differ from the biodistribution patterns of carrier-added Re-188 HEDP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10382850     DOI: 10.1016/s0969-8051(99)00007-4

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  3 in total

1.  188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases.

Authors:  Amal A El-Mabhouh; John R Mercer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-02-12       Impact factor: 9.236

2.  Preparation, Characterization, and Preliminary Imaging Study of [188Re]Re-Ibandronate as a Novel Theranostic Radiopharmaceutical for Bone Metastasis.

Authors:  Tingting Xu; Yingwei Wang; Zan Chen; Hanxiang Liu; Songsong Yang; Guangfu Liu; Yan Zhao; Wenhui Fu; Lin Liu; Ke Xiang; Dengsai Peng; Yue Chen
Journal:  Contrast Media Mol Imaging       Date:  2022-02-25       Impact factor: 3.161

Review 3.  188Re-HEDP therapy in the therapy of painful bone metastases.

Authors:  Knut Liepe
Journal:  World J Nucl Med       Date:  2018 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.